Almirall launches the open innovation platform AlmirallShare with the aim of finding advanced small molecules that could be used in the therapeutic treatment of atopic dermatitis, psoriasis, acne, actinic keratosis, and related dermatological diseases.

The call is addressed to universities, research centers, biotech companies, start-ups, and pharma companies all over the world with research compounds that have shown good potency and an acceptable pharmacokinetic profile or development compounds that have shown a good human safety profile. 

Submitting a proposal is as easy as going to sharedinnovation.almirall.com.